Glaxis Capital Management’s Healthcare Services Acquisition Corporation Warrant HCARW Stock Holding History

Glaxis Capital Management’s Portfolio HCARW Stock Details HCARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-135,000	Closed	-$4K	–	18
2022 Q3	$4K	Hold	135,000	–	–	0.06%	15
2022 Q2	$14K	Hold	135,000	–	–	0.21%	15
2022 Q1	$46K	Hold	135,000	–	–	0.07%	37
2021 Q4	$70K	Hold	135,000	–	–	0.19%	24
2021 Q3	$89K	Hold	135,000	–	–	0.19%	29
2021 Q2	$120K	Buy	135,000 +4,000	+3%	+$2.92K	0.15%	40
2021 Q1	$83K	Buy	+131,000	New	+$161K	0.09%	32

Glaxis Capital Management's HCARW Position: Q4 2022 in Review

Glaxis Capital Management sold out of Healthcare Services Acquisition Corporation Warrant (HCARW) in Q4 2022, closing a stake of 135,000 shares — an estimated $4K sold.

Glaxis Capital Management first reported a position in HCARW in Q1 2021 and held it in 7 quarters. The position peaked at $120K in Q2 2021. 0 funds tracked by Wall St. Rank hold HCARW as of Q4 2022.

Glaxis Capital Management reported no remaining Healthcare Services Acquisition Corporation Warrant position as of Q4 2022 after selling out during the quarter.
Glaxis Capital Management sold 135,000 Healthcare Services Acquisition Corporation Warrant shares in Q4 2022, an estimated $4K.
Glaxis Capital Management first reported a position in Healthcare Services Acquisition Corporation Warrant in Q1 2021 and held it in 7 quarters.
Glaxis Capital Management's Healthcare Services Acquisition Corporation Warrant position peaked at $120K in Q2 2021.
0 funds tracked by Wall St. Rank held Healthcare Services Acquisition Corporation Warrant as of Q4 2022.

Based on Glaxis Capital Management's 13F filing for Q4 2022, filed 10 Feb 2023.